The global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1143.56 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The dental membrane and bone graft substitute market comprises products that are used to treat and regenerate damaged bones and soft tissues in dental procedures. Bone graft substitutes are implanted to encourage new bone formation and tissue regeneration at the implant site. Dental membranes act as a barrier to prevent soft tissues from growing into the bone graft area and to hold the bone graft in place. They promote bone regeneration by isolating the graft from the surrounding soft tissues. The increasing number of dental implant procedures and demand for advanced dental treatment options is expected to drive the market growth over the forecast period.
Market key trends:
The rising geriatric population susceptible to dental problems as well as growing dental tourism in developing regions are some of the major factors aiding the market growth. As per the WHO, approx. 30% of adults aged 65-74 have no natural teeth in Japan, while it is 66% in the UK. This indicates significant demand for dental treatment and bone graft substitutes in the aging population. Furthermore, companies are increasingly investing in R&D of new technologies such as 3D-printed bone graft materials and tissue-engineered bone substitutes made from bioabsorbable materials. Development of advanced products with enhanced bone regeneration properties and easy handling characteristics is expected to positively influence the dental membrane and bone graft substitute market over the forecast period.
Porter’s Analysis
Threat of new entrants: Low barriers to entry in the dental membrane and bone graft substitute market makes the threat of new entrants moderate. Established players dominate the market through strong brand name.
Bargaining power of buyers: Large number of buyers in the market increases their bargaining power. Buyers can easily switch between suppliers based on price and product offerings.
Bargaining power of suppliers: Presence of many suppliers and ease of switching suppliers makes their bargaining power weak against large buyers in the dental membrane and bone graft substitute market.
Threat of new substitutes: Low threat due to lack of effective substitutes for bone graft materials in dental procedures. Regulatory restrictions further limit new substitutes.
Competitive rivalry: Intense competition exists among strong brands in varying product segments of the market. Players compete on product features, quality, and pricing.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing accidents, ageing population and dental disorders requiring grafting procedures.
Regional analysis: North America dominates the dental membrane and bone graft substitute market due to growing cosmetic dentistry trends and availability of advanced healthcare infrastructure. Asia Pacific exhibits the fastest growth with increasing medical tourism and spend on dental care in China and India.
Key players: Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp. are operating in the dental membrane and bone graft substitute market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
